TP53 and neoplasm: For instance, by establishing and employing two SCC tumor lines, TAb2 vs. TCh3, both of which harbor TP53 deletion and PIK3CA hyperactivation, we uncovered tumor-intrinsic differences that may underlie the differential responses to ICI (18).